$0.89
-0.01 (-0.73%)
Open$0.91
Previous Close$0.90
Day High$0.95
Day Low$0.88
52W High$1.31
52W Low$0.57
Volume—
Avg Volume360.8K
Market Cap41.31M
P/E Ratio—
EPS$-0.18
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+808.9% upside
Current
$0.89
$0.89
Target
$8.12
$8.12
$6.66
$8.12 avg
$12.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 18.37M | 11.53M | 9.68M |
| Net Income | -7,675,979 | -4,335,078 | 2.71M |
| Profit Margin | -41.8% | -39.7% | 28.0% |
| EBITDA | -9,185,351 | -5,475,704 | 3.39M |
| Free Cash Flow | — | — | 1.90M |
| Rev Growth | +59.4% | +59.4% | +15.5% |
| Debt/Equity | — | — | 0.16 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |